1. Home
  2. TBPH vs LGTY Comparison

TBPH vs LGTY Comparison

Compare TBPH & LGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • LGTY
  • Stock Information
  • Founded
  • TBPH 2013
  • LGTY 1970
  • Country
  • TBPH United States
  • LGTY United States
  • Employees
  • TBPH N/A
  • LGTY N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • LGTY
  • Sector
  • TBPH Health Care
  • LGTY
  • Exchange
  • TBPH Nasdaq
  • LGTY NYSE
  • Market Cap
  • TBPH 485.8M
  • LGTY 411.9M
  • IPO Year
  • TBPH N/A
  • LGTY N/A
  • Fundamental
  • Price
  • TBPH $9.59
  • LGTY $10.82
  • Analyst Decision
  • TBPH Buy
  • LGTY
  • Analyst Count
  • TBPH 4
  • LGTY 0
  • Target Price
  • TBPH $13.75
  • LGTY N/A
  • AVG Volume (30 Days)
  • TBPH 217.1K
  • LGTY 376.7K
  • Earning Date
  • TBPH 11-12-2024
  • LGTY 02-20-2025
  • Dividend Yield
  • TBPH N/A
  • LGTY 4.07%
  • EPS Growth
  • TBPH N/A
  • LGTY N/A
  • EPS
  • TBPH N/A
  • LGTY 0.30
  • Revenue
  • TBPH $63,192,000.00
  • LGTY $102,402,000.00
  • Revenue This Year
  • TBPH $11.41
  • LGTY N/A
  • Revenue Next Year
  • TBPH $37.36
  • LGTY N/A
  • P/E Ratio
  • TBPH N/A
  • LGTY $35.95
  • Revenue Growth
  • TBPH 15.93
  • LGTY N/A
  • 52 Week Low
  • TBPH $7.44
  • LGTY $8.41
  • 52 Week High
  • TBPH $11.71
  • LGTY $12.30
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 50.13
  • LGTY N/A
  • Support Level
  • TBPH $9.62
  • LGTY N/A
  • Resistance Level
  • TBPH $10.08
  • LGTY N/A
  • Average True Range (ATR)
  • TBPH 0.31
  • LGTY 0.00
  • MACD
  • TBPH -0.06
  • LGTY 0.00
  • Stochastic Oscillator
  • TBPH 25.00
  • LGTY 0.00

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About LGTY LOGILITY SUPPLY CHAIN SOLUTIONS INC

Logility Supply Chain Solutions Inc develops enterprise management and supply chain-related software and services. Its Services include Scenario Planning Products, Demand Planning InventoryAI+, Supply, Deployment, Supply Chain Data Management, and Supply Chain Design. The group provides services to various industries such as Food and Beverage Consumer Packaged Goods, Process Manufacturing, Industrial Manufacturing, Chemicals, and others.

Share on Social Networks: